research communications
(R)-Baclofen [(R)-4-amino-3-(4-chlorophenyl)butanoic acid]
aUniversity of Rostock, Institute of Chemistry, Biocatalytic synthesis group, Albert-Einstein-Str. 3A, 18059 Rostock, Germany, and bUniversity of Rostock, Institute of Chemistry, X-ray structure analytics, Albert-Einstein-Str. 3A, 18059 Rostock, Germany
*Correspondence e-mail: jan.langermann@uni-rostock.de
This article provides the first single-crystal XRD-based structure of enantiopure (R)-baclofen (form C), C10H12ClNO2, without any co-crystallized substances. In the enantiopure title compound, the molecules arrange themselves in an orthorhombic (space group P212121). In the crystal, strong hydrogen bonds and C—H⋯Cl bonds interconnect the zwitterionic molecules.
Keywords: crystal structure; (R)-baclofen; enantiopure; hydrogen bonds.
CCDC reference: 2125567
1. Chemical context
(R)-Baclofen, an unnatural β-amino acid and artificial GABA receptor agonist, is a frequently used non-addictive drug to treat muscle spasticity (Dario & Tomei, 2004). Although baclofen is conventionally applied as a only the (R)-enantiomer actually mediates a therapeutic effect (Olpe et al., 1978). In addition, baclofen has been recently approved in France as an alternative medication to treat alcohol dependence (Reade, 2021). Considering those new developments, the establishment of synthetic routes towards enantiopure (R)-baclofen were discussed recently (Córdova-Villanueva et al., 2018; Gendron et al., 2019).
2. Structural commentary
The molecular structure of the title compound is shown in Fig. 1. A partial packing diagram is shown in Fig. 2.
A prediction of crystal forms of the title compound was previously presented by Couvrat et al. (2021), which is based on detailed XRPD-studies and Based on the available XRPD-data, three forms, A, B and C, were observed, of which form C is considered to be the most stable form at higher temperatures. The (R)-baclofen crystal analyzed in this work corresponds to the newly predicted polymorphic form C presented by Couvrat et al. (2021).
The molecules crystallize in a zwitterionic configuration, forming an ammonium and a carboxylate residue. The N-bound hydrogen atoms were located and refined freely. Bond lengths and angles fall into the typically observed ranges for organic molecules without any strain.
3. Supramolecular features
In the crystal of enantiopure (R)-baclofen form C, short N—H⋯O hydrogen bonds occur between the carboxylate and the ammonium group of the neighboring baclofen molecule. In parallel, additional hydrogen bonding occurs with neighboring baclofen molecules, resulting in a two-dimensional network parallel to (001), which yields a layered formation of baclofen molecules. Parallel to the hydrogen bonding, T-shaped C—H⋯π interactions occur along the layers of aromatic rings within the molecules [C9—H9 ⋯ Cg1viii= 2.74 Å; C6—H6 ⋯ Cg1ix= 3.24 Å; symmetry codes: (viii) −x + 2, y − , −z + ; (ix) −x + 1, y + , −z + ; Cg1 is the centroid of the C5–C10 benzene ring] . The interaction planes both form angles of 67° with the plane of the corresponding benzene ring (C5–C10).
The combination of both effects yields the observed structure of form C of (R)-baclofen. In contrast, the cohesion of the apparently less stable form A is ensured by π–π interactions.
Hydrogen-bond geometry data as well as non-classical C—H⋯Cl interaction data are summarized in Table 1.
4. Database survey
Using the CSD database (version 5.42 updates 2 and 3; Groom et al., 2016), a search for the title compound's structure and names used in this article was conducted with CONQUEST (version 2021.2.0; Bruno et al., 2002).
While the crystal structures of (R)- and (S)-baclofenium hydrochloride were reported in the early 1980s (Chang et al., 1981, 1982; refcodes: CRBMZB, CRBMZC10), studies on the phase behavior of pure baclofen have gained attention just recently. This is particularly relevant for the of enantiomerically pure (R)-baclofen since X-ray powder diffraction studies were recently described by Couvrat et al. (2021). A total of three polymorphic forms (A, B and C) of (R)-baclofen were analyzed by X-ray powder diffraction, form C being identified as previously unknown. Based on this nomenclature, the of form C is reported in this study. For the of racemic baclofen, see Maniukiewicz et al. (2016; refcode: AQEKUE). A further array of racemic baclofenium structures with various carboxylic acids were published by Báthori & Kilinkissa (2015; refcodes: LUSXAA, LUSXEE, LUSXII, LUSXUU, LUSXOO, LUSYAB) and Malapile et al. (2021; refcodes: LABJIL, LABJOR, LABJUX, LABKAE, LABKEI, LABKIM, LABKOS). Additionally, Gendron et al. (2019; refcode: WONSIE01) presented the of (R)-baclofen hydrogenium maleate.
5. Synthesis and crystallization
Crystals of the title compound were grown from a saturated aqueous solution containing enantiopure (R)-baclofen, which was evaporated slowly by a stream of dry argon at 313 K. The purity of the (R)-baclofen was verified via 1H NMR. Enantiopure (R)-baclofen was purchased from abcr GmbH (Karlsruhe, Germany) under the name (R)-4-amino-3-(4-chlorophenyl)butanoic acid.
6. Refinement
Crystal data, data collection and structure . The N-bound hydrogen atoms were found in difference syntheses, and refined freely. All C-bound H atoms were positioned geometrically and refined using a riding model, with C—H = 0.99 Å (methylene groups), 1.00 Å (methine groups) or 0.95 Å (aryl CH) and with Uiso(H) = 1.2Ueq(C) (methylene groups, aryl CH, methine groups). The structure was refined as a two-component (BASF 0.04470).
details are summarized in Table 2
|
Supporting information
CCDC reference: 2125567
https://doi.org/10.1107/S2056989021012809/yz2013sup1.cif
contains datablock I. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S2056989021012809/yz2013Isup2.hkl
Supporting information file. DOI: https://doi.org/10.1107/S2056989021012809/yz2013Isup3.cml
Data collection: APEX2 (Bruker, 2003); cell
APEX2 (Bruker, 2003); data reduction: SAINT (Bruker, 2003); program(s) used to solve structure: SHELXT (Sheldrick, 2015a); program(s) used to refine structure: SHELXL2014/7 (Sheldrick, 2015b); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: SHELXL2014/7 (Sheldrick, 2015b).C10H12ClNO2 | Dx = 1.356 Mg m−3 |
Mr = 213.66 | Mo Kα radiation, λ = 0.71073 Å |
Orthorhombic, P212121 | Cell parameters from 9871 reflections |
a = 6.8913 (5) Å | θ = 2.8–33.0° |
b = 7.6898 (5) Å | µ = 0.34 mm−1 |
c = 19.7527 (14) Å | T = 123 K |
V = 1046.75 (13) Å3 | Block, colourless |
Z = 4 | 0.27 × 0.19 × 0.16 mm |
F(000) = 448 |
Bruker D8 QUEST diffractometer | 3796 independent reflections |
Radiation source: microfocus sealed tube | 3447 reflections with I > 2σ(I) |
Detector resolution: 10.4167 pixels mm-1 | Rint = 0.042 |
phi and ω scans | θmax = 32.5°, θmin = 2.1° |
Absorption correction: multi-scan (SADABS2016/2; Krause et al., 2015) | h = −10→10 |
Tmin = 0.662, Tmax = 0.747 | k = −11→11 |
23624 measured reflections | l = −29→29 |
Refinement on F2 | Hydrogen site location: mixed |
Least-squares matrix: full | H atoms treated by a mixture of independent and constrained refinement |
R[F2 > 2σ(F2)] = 0.033 | w = 1/[σ2(Fo2) + (0.0372P)2 + 0.2629P] where P = (Fo2 + 2Fc2)/3 |
wR(F2) = 0.082 | (Δ/σ)max = 0.001 |
S = 1.07 | Δρmax = 0.36 e Å−3 |
3796 reflections | Δρmin = −0.30 e Å−3 |
140 parameters | Absolute structure: Refined as an inversion twin |
0 restraints | Absolute structure parameter: 0.04 (6) |
Primary atom site location: dual |
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. Least-squares planes (x,y,z in crystal coordinates) and deviations from them (* indicates atom used to define plane) 3.7985 (0.0046) x + 6.4064 (0.0034) y + 0.9085 (0.0146) z = 5.2962 (0.0108) * 0.0030 (0.0012) C5 * -0.0067 (0.0012) C6 * 0.0039 (0.0013) C7 * 0.0025 (0.0013) C8 * -0.0062 (0.0014) C9 * 0.0035 (0.0014) C10 2.7365 (0.0020) H9_$8 3.2353 (0.0036) H6_$9 Rms deviation of fitted atoms = 0.0046 3.7985 (0.0045) x - 6.4064 (0.0034) y + 0.9085 (0.0145) z = 0.4604 (0.0136) Angle to previous plane (with approximate esd) = 67.162 ( 0.045 ) * -0.0030 (0.0012) C5_$8 * 0.0067 (0.0012) C6_$8 * -0.0039 (0.0013) C7_$8 * -0.0025 (0.0014) C8_$8 * 0.0062 (0.0014) C9_$8 * -0.0035 (0.0014) C10_$8 Rms deviation of fitted atoms = 0.0046 3.7985 (0.0045) x + 6.4064 (0.0034) y - 0.9085 (0.0145) z = 7.2622 (0.0039) Angle to previous plane (with approximate esd) = 66.899 ( 0.045 ) * -0.0030 (0.0012) C5_$6 * 0.0067 (0.0012) C6_$6 * -0.0039 (0.0013) C7_$6 * -0.0025 (0.0013) C8_$6 * 0.0062 (0.0014) C9_$6 * -0.0035 (0.0014) C10_$6 Rms deviation of fitted atoms = 0.0046 |
Refinement. Refined as a 2-component inversion twin (BASF 0.04470). |
x | y | z | Uiso*/Ueq | ||
Cl1 | 0.90826 (7) | 0.16066 (7) | 0.88304 (2) | 0.02370 (11) | |
N1 | 0.5842 (2) | 0.60260 (18) | 0.52352 (7) | 0.0134 (2) | |
O1 | 0.76064 (19) | 0.02092 (17) | 0.54492 (7) | 0.0194 (3) | |
O2 | 0.45342 (19) | −0.06602 (16) | 0.53636 (7) | 0.0178 (3) | |
C1 | 0.5825 (3) | 0.0466 (2) | 0.54937 (7) | 0.0123 (3) | |
C2 | 0.5085 (2) | 0.2255 (2) | 0.57066 (9) | 0.0147 (3) | |
H2A | 0.4081 | 0.2098 | 0.6060 | 0.018* | |
H2B | 0.4454 | 0.2809 | 0.5311 | 0.018* | |
C3 | 0.6643 (2) | 0.3497 (2) | 0.59801 (8) | 0.0124 (3) | |
H3 | 0.7818 | 0.3378 | 0.5687 | 0.015* | |
C4 | 0.5966 (3) | 0.5388 (2) | 0.59429 (8) | 0.0139 (3) | |
H4A | 0.4674 | 0.5490 | 0.6159 | 0.017* | |
H4B | 0.6882 | 0.6130 | 0.6199 | 0.017* | |
C5 | 0.7231 (2) | 0.3034 (2) | 0.67012 (8) | 0.0134 (3) | |
C6 | 0.6148 (2) | 0.3582 (2) | 0.72594 (8) | 0.0160 (3) | |
H6 | 0.5005 | 0.4248 | 0.7190 | 0.019* | |
C7 | 0.6719 (3) | 0.3166 (2) | 0.79192 (8) | 0.0173 (3) | |
H7 | 0.5986 | 0.3560 | 0.8297 | 0.021* | |
C8 | 0.8370 (3) | 0.2172 (2) | 0.80119 (8) | 0.0176 (3) | |
C9 | 0.9459 (3) | 0.1590 (3) | 0.74684 (9) | 0.0223 (4) | |
H9 | 1.0580 | 0.0896 | 0.7540 | 0.027* | |
C10 | 0.8886 (3) | 0.2037 (2) | 0.68165 (8) | 0.0200 (3) | |
H10 | 0.9639 | 0.1655 | 0.6442 | 0.024* | |
H1A | 0.701 (5) | 0.586 (4) | 0.5031 (16) | 0.044 (8)* | |
H1B | 0.555 (4) | 0.721 (3) | 0.5245 (11) | 0.022 (6)* | |
H1C | 0.490 (4) | 0.557 (4) | 0.5021 (14) | 0.029 (7)* |
U11 | U22 | U33 | U12 | U13 | U23 | |
Cl1 | 0.02181 (19) | 0.0335 (2) | 0.01578 (16) | 0.0041 (2) | −0.00328 (16) | 0.00057 (16) |
N1 | 0.0134 (6) | 0.0094 (6) | 0.0174 (6) | 0.0003 (5) | −0.0012 (5) | 0.0000 (4) |
O1 | 0.0152 (6) | 0.0173 (6) | 0.0258 (6) | 0.0016 (5) | 0.0031 (5) | −0.0055 (5) |
O2 | 0.0167 (6) | 0.0096 (5) | 0.0272 (6) | −0.0011 (4) | −0.0027 (5) | −0.0011 (5) |
C1 | 0.0156 (7) | 0.0097 (6) | 0.0117 (6) | 0.0006 (6) | 0.0003 (6) | 0.0009 (5) |
C2 | 0.0147 (7) | 0.0091 (6) | 0.0202 (7) | 0.0006 (6) | −0.0025 (6) | −0.0018 (6) |
C3 | 0.0130 (6) | 0.0099 (6) | 0.0144 (6) | 0.0013 (6) | −0.0013 (5) | −0.0010 (5) |
C4 | 0.0159 (7) | 0.0104 (6) | 0.0155 (6) | 0.0015 (6) | −0.0012 (6) | −0.0012 (5) |
C5 | 0.0133 (7) | 0.0100 (7) | 0.0169 (7) | 0.0006 (5) | −0.0013 (5) | −0.0010 (5) |
C6 | 0.0146 (7) | 0.0146 (7) | 0.0187 (7) | 0.0028 (6) | 0.0015 (5) | 0.0012 (6) |
C7 | 0.0186 (7) | 0.0171 (8) | 0.0163 (7) | 0.0010 (7) | 0.0029 (6) | 0.0004 (6) |
C8 | 0.0188 (8) | 0.0188 (8) | 0.0151 (7) | 0.0001 (6) | −0.0025 (6) | 0.0002 (6) |
C9 | 0.0200 (9) | 0.0276 (9) | 0.0194 (7) | 0.0115 (8) | −0.0034 (6) | 0.0002 (7) |
C10 | 0.0188 (8) | 0.0243 (9) | 0.0169 (7) | 0.0090 (7) | −0.0015 (6) | −0.0030 (6) |
Cl1—C8 | 1.7445 (17) | C3—H3 | 1.0000 |
N1—C4 | 1.484 (2) | C4—H4A | 0.9900 |
N1—H1A | 0.91 (3) | C4—H4B | 0.9900 |
N1—H1B | 0.93 (3) | C5—C10 | 1.394 (2) |
N1—H1C | 0.85 (3) | C5—C6 | 1.396 (2) |
O1—C1 | 1.247 (2) | C6—C7 | 1.398 (2) |
O2—C1 | 1.268 (2) | C6—H6 | 0.9500 |
C1—C2 | 1.526 (2) | C7—C8 | 1.383 (3) |
C2—C3 | 1.535 (2) | C7—H7 | 0.9500 |
C2—H2A | 0.9900 | C8—C9 | 1.384 (2) |
C2—H2B | 0.9900 | C9—C10 | 1.390 (2) |
C3—C5 | 1.523 (2) | C9—H9 | 0.9500 |
C3—C4 | 1.529 (2) | C10—H10 | 0.9500 |
C4—N1—H1A | 109 (2) | C3—C4—H4A | 109.2 |
C4—N1—H1B | 108.4 (14) | N1—C4—H4B | 109.2 |
H1A—N1—H1B | 110 (3) | C3—C4—H4B | 109.2 |
C4—N1—H1C | 112.1 (19) | H4A—C4—H4B | 107.9 |
H1A—N1—H1C | 114 (2) | C10—C5—C6 | 118.31 (15) |
H1B—N1—H1C | 104 (2) | C10—C5—C3 | 119.94 (14) |
O1—C1—O2 | 124.61 (16) | C6—C5—C3 | 121.76 (14) |
O1—C1—C2 | 119.43 (15) | C5—C6—C7 | 121.13 (15) |
O2—C1—C2 | 115.95 (15) | C5—C6—H6 | 119.4 |
C1—C2—C3 | 115.09 (14) | C7—C6—H6 | 119.4 |
C1—C2—H2A | 108.5 | C8—C7—C6 | 118.76 (15) |
C3—C2—H2A | 108.5 | C8—C7—H7 | 120.6 |
C1—C2—H2B | 108.5 | C6—C7—H7 | 120.6 |
C3—C2—H2B | 108.5 | C7—C8—C9 | 121.46 (16) |
H2A—C2—H2B | 107.5 | C7—C8—Cl1 | 119.47 (13) |
C5—C3—C4 | 110.37 (13) | C9—C8—Cl1 | 119.07 (14) |
C5—C3—C2 | 111.71 (14) | C8—C9—C10 | 119.01 (16) |
C4—C3—C2 | 111.18 (13) | C8—C9—H9 | 120.5 |
C5—C3—H3 | 107.8 | C10—C9—H9 | 120.5 |
C4—C3—H3 | 107.8 | C9—C10—C5 | 121.32 (16) |
C2—C3—H3 | 107.8 | C9—C10—H10 | 119.3 |
N1—C4—C3 | 112.15 (12) | C5—C10—H10 | 119.3 |
N1—C4—H4A | 109.2 | ||
O1—C1—C2—C3 | −11.2 (2) | C10—C5—C6—C7 | 0.9 (3) |
O2—C1—C2—C3 | 169.78 (14) | C3—C5—C6—C7 | −179.16 (16) |
C1—C2—C3—C5 | −76.36 (17) | C5—C6—C7—C8 | −1.0 (3) |
C1—C2—C3—C4 | 159.86 (13) | C6—C7—C8—C9 | 0.1 (3) |
C5—C3—C4—N1 | 165.95 (14) | C6—C7—C8—Cl1 | −178.86 (14) |
C2—C3—C4—N1 | −69.51 (18) | C7—C8—C9—C10 | 0.8 (3) |
C4—C3—C5—C10 | −138.39 (16) | Cl1—C8—C9—C10 | 179.81 (16) |
C2—C3—C5—C10 | 97.37 (19) | C8—C9—C10—C5 | −0.9 (3) |
C4—C3—C5—C6 | 41.7 (2) | C6—C5—C10—C9 | 0.0 (3) |
C2—C3—C5—C6 | −82.53 (19) | C3—C5—C10—C9 | −179.86 (18) |
D—H···A | D—H | H···A | D···A | D—H···A |
N1—H1A···O2i | 0.91 (3) | 1.91 (3) | 2.820 (2) | 176 (3) |
N1—H1B···O2ii | 0.93 (3) | 1.80 (3) | 2.7149 (19) | 168 (2) |
N1—H1C···O1iii | 0.85 (3) | 1.93 (3) | 2.775 (2) | 174 (3) |
N1—H1B···Cl1iv | 0.93 (3) | 2.95 (2) | 3.3192 (14) | 105.3 (16) |
C4—H4A···Cl1v | 0.99 | 2.73 | 3.6306 (19) | 152 |
C4—H4B···Cl1vi | 0.99 | 2.81 | 3.5668 (19) | 134 |
Symmetry codes: (i) x+1/2, −y+1/2, −z+1; (ii) x, y+1, z; (iii) x−1/2, −y+1/2, −z+1; (iv) −x+3/2, −y+1, z−1/2; (v) −x+1, y+1/2, −z+3/2; (vi) −x+2, y+1/2, −z+3/2. |
Acknowledgements
Funding by the Central SME Innovation Programme (ZIM, project No. ZF4402103CR9) is gratefully acknowledged. The authors thank Isabel Schicht and Sandra Diederich for experimental and technical support.
Funding information
Funding for this research was provided by: Bundesministerium für Wirtschaft und Energie (grant No. ZF4402103CR9 to Dr Jan von Langermann).
References
Báthori, N. B. & Kilinkissa, O. E. Y. (2015). CrystEngComm, 17, 8264–8272. Google Scholar
Bruker (2003). Apex, V7, 51A SADABS, SAINT, SHELXTL and SMART. Bruker AXS Inc., Madison, Wisconsin, USA. Google Scholar
Bruno, I. J., Cole, J. C., Edgington, P. R., Kessler, M., Macrae, C. F., McCabe, P., Pearson, J. & Taylor, R. (2002). Acta Cryst. B58, 389–397. Web of Science CrossRef CAS IUCr Journals Google Scholar
Chang, C.-H., Yang, D. S. C., Yoo, C. S., Wang, B.-c., Pletcher, J. & Sax, M. (1981). Acta Cryst. A37, C71. CrossRef IUCr Journals Google Scholar
Chang, C.-H., Yang, D. S. C., Yoo, C. S., Wang, B.-C., Pletcher, J., Sax, M. & Terrence, C. F. (1982). Acta Cryst. B38, 2065–2067. CSD CrossRef CAS Web of Science IUCr Journals Google Scholar
Córdova-Villanueva, E. N., Rodríguez-Ruiz, C., Sánchez-Guadarrama, O., Rivera-Islas, J., Herrera-Ruiz, D., Morales-Rojas, H. & Höpfl, H. (2018). Cryst. Growth Des. 18, 7356–7367. Google Scholar
Couvrat, N., Sanselme, M., Poupard, M., Bensakoun, C., Drouin, S. H., Schneider, J.-M. & Coquerel, G. (2021). J. Pharm. Sci. 110, 3457–3463. Web of Science CrossRef CAS PubMed Google Scholar
Dario, A. & Tomei, G. (2004). Drug Saf. 27, 799–818. Web of Science CrossRef PubMed CAS Google Scholar
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854. Web of Science CrossRef CAS IUCr Journals Google Scholar
Gendron, F.-X., Mahieux, J., Sanselme, M. & Coquerel, G. (2019). Cryst. Growth Des. 19, 4793–4801. Web of Science CSD CrossRef CAS Google Scholar
Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. Web of Science CrossRef IUCr Journals Google Scholar
Krause, L., Herbst-Irmer, R., Sheldrick, G. M. & Stalke, D. (2015). J. Appl. Cryst. 48, 3–10. Web of Science CSD CrossRef ICSD CAS IUCr Journals Google Scholar
Malapile, R. J., Nyamayaro, K., Nassimbeni, L. R. & Báthori, N. B. (2021). CrystEngComm, 23, 91–99. Web of Science CSD CrossRef CAS Google Scholar
Maniukiewicz, W., Oracz, M. & Sieroń, L. (2016). J. Mol. Struct. 1123, 271–275. Web of Science CSD CrossRef CAS Google Scholar
Olpe, H.-R., Demiéville, H., Baltzer, V., Bencze, W. L., Koella, W. P., Wolf, P. & Haas, H. L. (1978). Eur. J. Pharmacol. 52, 133–136. CrossRef CAS PubMed Web of Science Google Scholar
Reade, M. C. (2021). JAMA, 325, 727–729. Web of Science CrossRef CAS PubMed Google Scholar
Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8. Web of Science CrossRef IUCr Journals Google Scholar
Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8. Web of Science CrossRef IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.